SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

HOWARD DAVID T

(Last)

(First)

(Middle)

C/O VIA PHARMACEUTICALS, INC

750 BATTERY STREET, SUITE 330

(Street)

SAN FRANCISCO

94111

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/31/2008

3. Issuer Name and Ticker or Trading Symbol
ANGIOTECH PHARMACEUTICALS INC [ ANPI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	30,800	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	04/01/2000⁽¹⁾	03/19/2010	Common Stock	30,000	$19.75	D
Options	04/01/2001⁽²⁾	03/05/2011	Common Stock	30,000	$17	D
Options	04/01/2001⁽³⁾	04/04/2011	Common Stock	10,000	$14.75	D
Options	08/01/2002⁽⁴⁾	07/18/2012	Common Stock	40,000	$13.465	D
Awards	12/01/2003⁽⁵⁾	01/21/2009	Common Stock	10,000	$31.85	D
Awards	07/01/2004⁽⁶⁾	06/09/2009	Common Stock	5,000	$27.75	D
Awards	01/01/2005⁽⁷⁾	11/30/2009	Common Stock	5,000	$21.93	D
Awards	06/10/2005⁽⁸⁾	06/08/2010	Common Stock	5,000	$16.1	D
Awards	01/01/2006⁽⁹⁾	11/30/2010	Common Stock	5,000	$17.11	D
Awards	07/01/2006⁽¹⁰⁾	06/07/2011	Common Stock	5,000	$14.86	D
Awards	01/01/2006⁽¹¹⁾	11/30/2011	Common Stock	5,000	$10.01	D
Awards	07/01/2007⁽¹²⁾	06/17/2012	Common Stock	5,000	$7.73	D
Awards	01/01/2008⁽¹³⁾	11/30/2012	Common Stock	5,000	$3.96	D
Options-AMI	03/09/2010⁽¹⁴⁾	03/08/2013	Common Stock	38,524	$15.44	D
Options-AMI	03/09/2008⁽¹⁵⁾	03/08/2012	Common Stock	38,524	$15.44	D

Explanation of Responses:

1. The option is currently exercisable as to all 30000 shares. The option became exercisable on 4/1/2000 having vested in 24 equal installments over two years with the last installment vesting on 3/1/2002.

2. The option is currently exercisable as to all 30000 shares. The option became exercisable on 4/1/2001 having vested in 24 equal installments over two years with the last installment vesting on 3/1/2003.

3. The option is currently exercisable as to all 10000 shares. The option became exercisable on 4/1/2001 having vested in 24 equal installments over two years with the last installment vesting on 3/1/2003.

4. The option is currently exercisable as to all 40000 shares. The option became exercisable on 8/1/2002 having vested in 48 equal installments over four years with the last installment vesting on 7/1/2004.

5. The option is currently exercisable as to all 10000 shares. The option became exercisable on 12/1/2003 having vested in 24 equal installments over two years with the last installment vesting on 12/1/2005.

6. The option is currently exercisable as to all 5000 shares. The option became exercisable on 7/1/2004 having vested in 24 equal installments over two years with the last installment vesting on 6/1/2006.

7. The option is currently exercisable as to all 5000 shares. The option became exercisable on 1/1/2005 having vested in 24 equal installments over two years with the last installment vesting on 12/1/2006.

8. The option is currently exercisable as to all 5000 shares. The option became exercisable on 6/10/2005 having vested in 24 equal installments over two years with the last installment vesting on 6/9/2007.

9. The option is currently exercisable as to all 5000 shares. The option became exercisable on 1/1/2006 having vested in 24 equal installments over two years with the last installment vesting on 12/1/2007.

10. The option is currently exercisable as to all 4375 shares. The option became exercisable on 7/1/2006 and will continue to vest with respect to the remaining 625 shares in equal installments on a monthly basis until 6/1/2008.

11. The option is currently exercisable as to all 33750 shares. The option became exercisable on 1/1/2006 and will continue to vest with respect to the remaining 26250 shares in equal installments on a monthly basis until 12/1/2009.

12. The option is currently exercisable as to all 1875 shares. The option became exercisable on 7/1/2007 and will continue to vest with respect to the remaining 3125 shares in equal installments on a monthly basis until 6/1/2009.

13. The option is currently exercisable as to all 625 shares. The option became exercisable on 1/1/2008 and will continue to vest with respect to the remaining 4375 shares in equal installments on a monthly basis until 12/1/2009.

14. AMI Options: Conversion or Exercise Price is in US Dollars. The option is not currently exercisable as to any shares. The option will become exercisable on 3/9/2010 and will continue to vest with respect to the remaining 38522 shares in equal installments on an annual basis until 3/8/2013.

15. AMI Options: Conversion or Exercise Price is in US Dollars. The option is currently exercisable as to 9631 shares. The option will become exercisable on 3/9/2008 and will continue to vest with respect to the remaining 28891 shares in equal installments on an annual basis until 3/8/2012.

Remarks:

All "4. Conversion or Exercise Price" amounts are in Canadian funds, except (14) which is in US funds.

	/s/ David T. Howard	04/10/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.